Key facts
- This page summarizes Mark Douglas Smith's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 18 May 2022, 16:20.
Mark Douglas Smith - 17 May 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)
- Role
- Director
- Signature
- /s/ Adam C. Vandervoort, Attorney-in-Fact
- Issuer symbol
- TDOC
- Transactions as of
- 17 May 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 18 May 2022, 16:20:45 UTC
- Previous filing
- 06 Dec 2021
- Next filing
- 31 May 2022
- SEC
- View on sec.gov
Key filing fact
Mark Douglas Smith filed Form 4 for Teladoc Health, Inc. (TDOC) on 18 May 2022.
Change
- Previous filing in this sequence was filed on 06 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
TDOC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +819
- Change %
- +23%
- Price
- Shares after
- 4,355
- Date
- 17 May 2022
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
TDOC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -819
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 819
- Date
- 17 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 819
- Exercise price
- Footnotes
- F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| F3 | On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |